Upperton Completes Sterile Manufacturing Facility in UK

UK contract development and manufacturing organization (CDMO) Upperton Pharma Solutions, has completed its new sterile manufacturing facility in Nottingham, UK, expanding its capacity in addition to its existing 50,000-square-foot site at Trent Gateway.

The 7,000-square-foot facility will support the manufacturing of aseptic and terminally sterilized small volume liquids and powders for parenteral, nasal and pulmonary delivery.

According to Upperton, the new facility has the capability to support formulation development, clinical manufacture and analytical testing, with batch sizes of up to 2,000 vials, pre-filled syringes and pre-filled cartridges for liquid formulations and pre-sterilized powders.

Nikki Whitfield, Upperton’s CEO, said: “The combined experience of our leadership team in sterile facility builds and subsequent operations ensures that we are ideally placed as a CDMO partner of choice for small to mid-sized biotech and pharma looking to get into the clinic quickly with fast access to sterile manufacturing services.”

Left to right: Upperton executives Paul Kelsall (Director of Clinical...
Left to right: Upperton executives Paul Kelsall (Director of Clinical Manufacturing), Nikki Whitfield (CEO), Ian Lafferty (Chief Technical Officer), and Jon Austwick (Director of Quality & Compliance) │ © Upperton Pharma Solutions

Company

Upperton Pharma Solutions

Albert Einstein Centre, Nottingham Science Park
NG7 2TN Nottingham
UK

Company contact







Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis